...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

Depending WHERE you hold your shares that may be possible.  I have been advised that because it is the OTC that they cannot be held in any registered accounts (RRSP, TFSA etc)  I am just in the process of trying to buy a few for my non registered account.  

Share
New Message
Please login to post a reply